News
GSK's vaccine against respiratory syncytial virus (RSV) is one of ... with the final results of Pfizer's study and as the data from both studies is subjected to scrutiny. The two companies say ...
Pfizer (PFE) stock draws public scrutiny as a House probe gathers new allegations regarding the company's COVID-19 vaccine ...
Pfizer has bolstered the evidence behind its respiratory syncytial virus (RSV) vaccine with a positive trial of the shot used to protect newborns, adding to earlier results in older adults. The ...
Both a maternal vaccine for RSV and a long-acting monoclonal antibody for infants and young children aged 0-19 months (nirsevimab) were in use during the 2024-2025 RSV season, wrote Monica Patton ...
The HER2-targeted antibody-drug conjugate that Pfizer gained from its Seagen buyout has delivered positive results in a pivotal study among Chinese patients with newly diagnosed bladder cancer ...
A former critic of FDA and Pharma will now oversee the regulation of costly and complicated biologics like vaccines, gene therapies, and blood supply.
Members of a Massachusetts legislative commission tasked with combating antisemitism pushed back against criticisms levied by scores of rabbis and Jewish community members. On April 29th, 90 ...
This agreement, finalized in May 2021, involved the EU committing to purchase up to 1.8 billion doses of the Pfizer-BioNTech Covid-19 vaccine, the largest by far of all the deals signed by Brussels.
Offensive tackle Anthony Belton was a surprise pick towards the end of Round 2, as most teams considered him no better than a late third-round prospect. Belton possesses the size, athleticism, and ...
The LC16m8 vaccine, an attenuated ... Vaccines of the Future: Harnessing the Immune System for Long-Lasting Protection May 7, 2025 — Scientists have uncovered a promising new way to enhance the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results